Tenon Medical, Inc.
TNONNasdaq
$0.20
↑ +1.7%Jul 17 close · end-of-day
Price
1Y↓ -80.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2,269.38
Enterprise Value
-$4.6M
P/E
—
P/S
0.0
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$4.6M
Net Income (TTM)
-$12.4M
Free Cash Flow (TTM)
—
Gross Margin
64.8%
Operating Margin
-269.6%
Net Margin
-270.1%
ROE
-655.2%
ROIC
—
Debt / Equity
—
Net Cash
$4.6M
Return 1Y
-81.3%
Company profile
Tenon Medical, Inc. develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery. The company was incorporated in 2012 and is based in Los Gatos, California.
- CEO
- Steven M. Foster
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 8
- Headquarters
- California
- Website
- tenonmed.com
Earnings
TNON Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.4M↑ +89.9%
Diluted EPS$0.31↓ -69.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $160,000.00 | $691,000.00 | $2.9M | $3.3M | $3.9M |
| Gross profit | $105,000.00 | -$641,000.00 | $1.2M | $1.7M | $2.4M |
| Operating income | -$6.5M | -$18.7M | -$15.7M | -$13.8M | -$12.8M |
| Net income | -$7.0M | -$18.9M | -$15.6M | -$13.7M | -$12.6M |
| Diluted EPS | -$7.81 | -$23.62 | -$68.64 | -$11.26 | -$1.70 |
| Operating cash flow | -$4.3M | -$12.0M | -$12.2M | -$9.9M | -$10.7M |
| Free cash flow | -$4.4M | -$12.9M | -$12.5M | -$10.1M | -$11.0M |
| Gross margin | 65.6% | -92.8% | 42.4% | 52.2% | 59.8% |
| Operating margin | -4038.1% | -2709.8% | -537.1% | -420.1% | -324.3% |
| Net margin | -4405.0% | -2737.6% | -532.1% | -417.2% | -318.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $901,000.00 | $887,000.00 | $770,000.00 | $726,000.00 | $564,000.00 | $1.2M | $1.5M | $1.4M |
| Gross profit | $470,000.00 | $418,000.00 | $353,000.00 | $323,000.00 | $245,000.00 | $773,000.00 | $1.0M | $945,000.00 |
| Operating income | -$3.9M | -$3.2M | -$3.2M | -$3.7M | -$2.9M | -$3.4M | -$2.9M | -$3.3M |
| Net income | -$3.8M | -$3.2M | -$3.1M | -$3.6M | -$2.8M | -$3.3M | -$2.8M | -$3.5M |
| Diluted EPS | -$8.16 | -$3.63 | $10.55 | $1.01 | -$0.36 | -$0.40 | -$1.95 | $0.31 |
| Operating cash flow | -$2.4M | -$2.3M | -$2.8M | -$2.5M | -$2.2M | -$3.8M | -$2.2M | -$3.0M |
| Free cash flow | -$2.4M | -$2.4M | -$2.8M | — | — | -$3.9M | — | -$3.0M |
| Gross margin | 52.2% | 47.1% | 45.8% | 44.5% | 43.4% | 65.9% | 68.7% | 68.5% |
| Operating margin | -429.7% | -362.5% | -412.1% | -506.5% | -506.6% | -289.2% | -193.5% | -237.9% |
| Net margin | -424.6% | -359.0% | -400.9% | -498.1% | -491.0% | -284.7% | -191.2% | -252.1% |
Company news
Jul 1, 2026
Jun 30, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.